000 | 01117cam a22003254a 4500 | ||
---|---|---|---|
003 | inmoiis | ||
005 | 20171014142957.0 | ||
020 | _a9780849390067 (hbk. : alk. paper) | ||
020 | _a0849390060 (hbk. : alk. paper) | ||
040 | _ainmoiis | ||
041 | _aEng | ||
044 | _aii | ||
082 | 0 | 0 |
_a615.19 _222 _bREK-C |
100 |
_aRekka,E.A. (ed.) _97973 |
||
245 | 0 | 0 |
_aChemistry and molecular aspects of drug design and action _c[edited by] E.A. Rekka |
260 |
_aBoca Raton _bCRC Press/Taylor & Francis, _c2008. |
||
300 |
_a356 p. _bill. |
||
500 | _aIncludes bibliographical references and index. | ||
650 | 0 |
_aPharmaceutical chemistry. _97974 |
|
650 | 0 |
_aDrugs _97975 |
|
650 | 1 | 2 |
_aChemistry, Pharmaceutical. _97976 |
650 | 2 | 2 |
_aDrug Design. _97977 |
650 | 2 | 2 |
_aPharmacologic Actions. _97978 |
700 | 1 |
_aRekka, E. A. _97979 |
|
700 | 1 |
_aKourounakis, P. N. _97980 |
|
902 | _0IISER Mohali | ||
942 |
_2ddc _cBK |
||
999 |
_c1833 _d1833 |